• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Regulus Therapeutics Inc

+ Add to Watchlist

RGLS:US

17.3300 USD 2.7900 19.19%

As of 17:20:00 ET on 10/24/2014.

Company Profile for Regulus Therapeutics Inc (RGLS)

Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulas's research consists of scientists from across the world.

Contact Information

Regulus Therapeutics Inc

1896 Rutherford Road
Carlsbad, CA 92008-7208
United States
Phone: 1-800-734-8587

Key Executives for Regulus Therapeutics Inc (RGLS)

Kleanthis G XanthopoulosPresident/CEODavid SzekeresChief Bus Ofcr/Secy/Gen Cnsl
Paul C GrintChief Medical OfficerNeil W GibsonChief Scientific Officer
Mary Yaroshevsky GlanvilleSenior VP:Human CapitalDaniel R ChevallardVP:Finance & Accounting
Victor KnopovVP:Pharmaceutical DevelopmentAmy ConradDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil